RK
Therapeutic Areas
Catena Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| TROP2-targeting MPC | Solid Tumors (TROP2-expressing) | Pre-clinical |
| GPC3-targeting program | Solid Tumors | Discovery/Pre-clinical |
| HER2-targeting program | Solid Tumors | Discovery/Pre-clinical |